These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3301560)

  • 1. Flunarizine as add-on therapy in epilepsy. Crossover study vs placebo.
    Moglia A; Bergamasco B; Di Perri R; Mancia D
    Funct Neurol; 1986; 1(4):547-50. PubMed ID: 3301560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of flunarizine in pediatric epilepsy.
    Cavazzuti GB; Galli V; Benatti A
    Funct Neurol; 1986; 1(4):551-4. PubMed ID: 3609882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flunarizine in therapy-resistant infantile epilepsies.
    Curatolo P; Cusmai R; Bruni O; Pruna D; Brindesi I
    Funct Neurol; 1986; 1(4):555-7. PubMed ID: 3609883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allopurinol as adjunctive therapy in intractable epilepsy: a double-blind and placebo-controlled trial.
    Togha M; Akhondzadeh S; Motamedi M; Ahmadi B; Razeghi S
    Arch Med Res; 2007 Apr; 38(3):313-6. PubMed ID: 17350481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of flunarizine therapy on intractable epilepsy.
    Nakane Y; Seino M; Yagi K; Kaji S; Yamauchi T
    Arzneimittelforschung; 1989 Jul; 39(7):793-8. PubMed ID: 2675853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind placebo-controlled trial with flunarizine in therapy-resistant epileptic patients.
    Fröscher W; Bülau P; Burr W; Penin H; Rao ML; de Beukelaar F
    Clin Neuropharmacol; 1988 Jun; 11(3):232-40. PubMed ID: 3042126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eslicarbazepine acetate: a double-blind, add-on, placebo-controlled exploratory trial in adult patients with partial-onset seizures.
    Elger C; Bialer M; Cramer JA; Maia J; Almeida L; Soares-da-Silva P
    Epilepsia; 2007 Mar; 48(3):497-504. PubMed ID: 17319919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures.
    Wu XY; Hong Z; Wu X; Wu LW; Wang XF; Zhou D; Zhao ZX; Lv CZ
    Epilepsia; 2009 Mar; 50(3):398-405. PubMed ID: 18657175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium antagonists as an add-on therapy for drug-resistant epilepsy.
    Chaisewikul R; Baillie N; Marson AG
    Cochrane Database Syst Rev; 2001; (4):CD002750. PubMed ID: 11687158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized double-blind study of flunarizine versus placebo in patients with chronic cerebrovascular disorders.
    Agnoli A; Manna V; Martucci N; Fioravanti M; Ferromilone F; Cananzi A; D'Andrea G; De Rosa A; Vizioli R; Sinforiani E
    Int J Clin Pharmacol Res; 1988; 8(3):189-97. PubMed ID: 3042644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Flunarizine in epilepsy. Evaluation of a 4-month supplementary treatment in patients resistant to treatment with existing antiepileptics].
    Sorel L
    Acta Neurol Belg; 1987; 87(3):140-7. PubMed ID: 3673491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying baseline characteristics of placebo responders versus nonresponders in randomized double-blind trials of refractory partial-onset seizures.
    Niklson I; Edrich P; Verdru P
    Epileptic Disord; 2006 Mar; 8(1):37-44. PubMed ID: 16567324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproate versus flunarizine in migraine prophylaxis: a randomized, double-open, clinical trial.
    Mitsikostas DD; Polychronidis I
    Funct Neurol; 1997; 12(5):267-76. PubMed ID: 9439944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of levetiracetam: a review of three pivotal clinical trials.
    Privitera M
    Epilepsia; 2001; 42 Suppl 4():31-5. PubMed ID: 11564123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.
    Beran RG; Berkovic SF; Black AB; Danta G; Hiersemenzel R; Schapel GJ; Vajda FJ
    Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Losigamone add-on therapy in partial epilepsy: a placebo-controlled study.
    Bauer J; Dienel A; Elger CE;
    Acta Neurol Scand; 2001 Apr; 103(4):226-30. PubMed ID: 11328193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of carisbamate for the treatment of migraine in a randomized, double-blind trial.
    Cady RK; Mathew N; Diener HC; Hu P; Haas M; Novak GP;
    Headache; 2009 Feb; 49(2):216-26. PubMed ID: 19222595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures.
    Brodie MJ; Duncan R; Vespignani H; Solyom A; Bitenskyy V; Lucas C
    Epilepsia; 2005 Jan; 46(1):31-41. PubMed ID: 15660766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind placebo-controlled trial of flunarizine as add-on therapy in refractory childhood epilepsy.
    Battaglia A; Ferrari AR; Guerrini R
    Brain Dev; 1991 Jul; 13(4):217-22. PubMed ID: 1957968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: analysis of two randomized, double-blind, placebo-controlled studies.
    Rosenfeld WE; Benbadis S; Edrich P; Tassinari CA; Hirsch E
    Epilepsy Res; 2009 Jul; 85(1):72-80. PubMed ID: 19327967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.